A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder | MicrobiomeTrials← Back to trialsNCT04375033
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2020-11-03Est. Completion: 2028-09-30
Enrollment target: 952 participants Locations- Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States
- Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California, United States
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California, United States
- San Francisco VA Medical Center, San Francisco, CA, San Francisco, California, United States
- CERC (VISN1, West Haven, CT), West Haven, Connecticut, United States
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States
- Wilmington VA Medical Center, Wilmington, DE, Wilmington, Delaware, United States
- Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines, Florida, United States
- North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota, United States
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States
Other microbiome trials you might be interested in
HivOpioid Use
The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in th…
New Haven, United StatesEst. completion Dec 2028
Opioid Use DisorderDual DiagnosisHousing ProblemsMental Disorder in AdolescenceRisk BehaviorHomelessness
Homelessness severely affects health and well-being and is particularly negative for youth. Between 70-95% of youth expe…
Columbus, United StatesEst. completion Dec 1, 2028
Dayton VA Medical Center, Dayton, OH, Dayton, Ohio, United StatesPhiladelphia MultiService Center, Philadelphia, PA, Philadelphia, Pennsylvania, United StatesVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania, United StatesProvidence VA Medical Center, Providence, RI, Providence, Rhode Island, United StatesVA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United StatesVA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United StatesWhite River Junction VA Medical Center, White River Junction, VT, White River Junction, Vermont, United StatesHampton VA Medical Center, Hampton, VA, Hampton, Virginia, United StatesSalem VA Medical Center, Salem, VA, Salem, Virginia, United StatesVA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United StatesHuntington VA Medical Center, Huntington, WV, Huntington, West Virginia, United StatesClement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee, Wisconsin, United StatesOpioid Use DisorderHealthy Volunteers
Background:
The purpose of this study is to understand how a type of brain stimulation, transcranial magnetic stimulati…
Baltimore, United StatesCompleted Aug 6, 2027